Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Claudins as markers for early detection, diagnosis, prognosis and as targets of therapy for breast and metastatic brain or bone cancer

Claudins as markers for early detection, diagnosis, prognosis and as targets of therapy for breast and metastatic brain or bone cancer

US Patent 8093013 · Granted Jan 10, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Quantitative multiplex methylation specific PCR method-CMethDNA, reagents, and i2025
Quantitative multiplex methylation specific PCR method—cMethDNA, reagents, and i2019
Genome-wide methylation analysis and use to identify genes specific to breast ca2019
HEYL as a therapeutic target and a diagnostic marker for neoplasia and uses ther2017
Quantitative multiplex methylation-specific PCR2016
Compositions and methods for treatment of tamoxifen resistant breast cancer2015
Quantitative multiplex methylation-specific PCR2014
Breast endothelial cell expression patterns2013
Quantitative multiplex methylation-specific PCR2011
Aberrantly methylated genes as markers of breast malignancy2010
Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gla2007
Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gla2005